PDUFA Talks: Four-Phase Review Flops; Automatic Extensions Back On Table

FDA and industry have moved to a more pointed debate of automatic review deadline extensions after the agency decided to drop its four-phase review process proposal.

More from Archive

More from Pink Sheet